✦ LIBER ✦

Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: Multicenter study

✍ Scribed by Nigishi Hotta; Nobuo Sakamoto; Yukio Shigeta; Ryuichi Kikkawa; Yoshio Goto

Book ID: 113410232
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 371 KB
Volume: 10
Category: Article
ISSN: 1056-8727
DOI: 10.1016/1056-8727(96)00113-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Clinical Effects of Epalrestat

Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

✍ Hotta, N.; Akanuma, Y.; Kawamori, R.; Matsuoka, K.; Oka, Y.; Shichiri, M.; Toyot 📂 Article 📅 2006 🏛 American Diabetes Association 🌐 English ⚖ 225 KB

The effect of an aldose reductase inhibi

The effect of an aldose reductase inhibitor (Epalrestat) on diabetic nephropathy in rats

✍ Iori Itagaki; Kiyoshi Shimizu; Yoshihisa Kamanaka; Kazuhiko Ebata; Ryuichi Kikka 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 782 KB

Effects of an aldose reductase inhibitor

Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study

✍ Y Goto; N Hotta; Y Shigeta; N Sakamoto; R Kikkawa 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 811 KB

Effect of 24 weeks of treatment with epa

Effect of 24 weeks of treatment with epalrestat, an aldose reductase inhibitor, on peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus

✍ Kenzo Uchida; Toshikazu Kigoshi; Shigeru Nakano; Takashi Ishii; Mitsutaka Kitaza 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 475 KB

Effects of epalrestat, an aldose reducta

Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of Nɛ-carboxymethyl lysine

✍ Toshihide Kawai; Izumi Takei; Mikiya Tokui; Osamu Funae; Kazunori Miyamoto; Mits 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 434 KB

Long-term effect of epalrestat, an aldos

Long-term effect of epalrestat, an aldose reductase inhibitor, on the development of incipient diabetic nephropathy in Type 2 diabetic patients

✍ Kaoru Iso; Hisaya Tada; Koji Kuboki; Toshiki Inokuchi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 114 KB